Altogether, these findings suggested that inadequate PRL suppression by dopamine agonists might alter metabolic homeostasis, triggering excessive body fat accumulation, insulin resistance and metabolic syndrome, and thus promoting the increase in overall cardiovascular risk. Here, PRL is linked to Insulin resistance.